​

Aura Biosciences (AURA) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChart

AURA Stock Forecast

Aura Biosciences (AURA) stock forecast, based on 7 Wall Street analysts, predicts a 12-month average price target of $22.75, with a high of $25.00 and a low of $19.00. This represents a 324.44% increase from the last price of $5.36.

$5 $9 $13 $17 $21 $25 High: $25 Avg: $22.75 Low: $19 Last Closed Price: $5.36

AURA Stock Rating

Aura Biosciences stock's rating consensus is Buy, based on 7 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 7 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 7 0 7 Strong Sell Sell Hold Buy Strong Buy

AURA Price Target Upside V Benchmarks

TypeNameUpside
StockAura Biosciences324.44%
SectorHealthcare Stocks 35.25%
IndustryBiotech Stocks 86.56%

Price Target Trends

1M3M12M
# Anlaysts226
Avg Price Target$22.00$22.00$22.33
Last Closing Price$5.36$5.36$5.36
Upside/Downside310.45%310.45%316.60%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 2534---7
Mar, 2534---7
Feb, 2534---7
Jan, 2534---7
Dec, 2435---8
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Mar 26, 2025Jonathan WollebenJMP Securities$19.00$5.99217.20%254.48%
Mar 25, 2025Edward WhiteH.C. Wainwright$25.00$7.08253.11%366.42%
Oct 18, 2024George FarmerScotiabank$23.00$10.29123.52%329.10%
Oct 18, 2024Ed White IIH.C. Wainwright$22.00$10.29113.80%310.45%
Oct 18, 2024Julian HarrisonBTIG$24.00$10.29133.24%347.76%
Jul 25, 2024Edward WhiteH.C. Wainwright$21.00$9.27126.54%291.79%
Nov 11, 2022JMP Securities$30.00$12.95131.66%459.70%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Mar 26, 2025CitigroupOutperformOutperformhold
Mar 25, 2025H.C. WainwrightBuyBuyhold
Oct 18, 2024Cowen & Co.BuyBuyhold
Oct 18, 2024ScotiabankOutperformOutperformhold
Oct 18, 2024ScotiabankSector OutperformSector Outperformhold
Oct 18, 2024H.C. WainwrightBuyBuyhold
Oct 18, 2024BTIGBuyBuyhold
Sep 13, 2024H.C. WainwrightBuyBuyhold
Sep 13, 2024JMP SecuritiesOutperformOutperformhold
Sep 12, 2024Cowen & Co.BuyBuyhold

Financial Forecast

EPS Forecast

Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.93$-1.75----
Avg Forecast$-1.84$-1.68$-2.04$-2.13$-2.57$-1.66
High Forecast$-1.84$-1.66$-1.84$-1.90$-2.10$-1.66
Low Forecast$-1.84$-1.70$-2.50$-2.36$-3.04$-1.66
Surprise %4.89%4.17%----

Revenue Forecast

$15M $34M $53M $72M $91M $110M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported------
Avg Forecast--$18.70M$19.20M$17.50M$109.20M
High Forecast--$18.70M$19.20M$17.50M$109.20M
Low Forecast--$18.70M$19.20M$17.50M$109.20M
Surprise %------

Net Income Forecast

$-125M $-113M $-101M $-89M $-77M $-65M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-76.41M$-86.92M----
Avg Forecast$-72.98M$-66.38M$-85.92M$-84.39M$-101.82M$-65.57M
High Forecast$-72.98M$-65.58M$-72.75M$-75.28M$-83.20M$-65.57M
Low Forecast$-72.98M$-67.17M$-99.10M$-93.50M$-120.44M$-65.57M
Surprise %4.69%30.95%----

AURA Forecast FAQ

Is Aura Biosciences stock a buy?

Aura Biosciences stock has a consensus rating of Buy, based on 7 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 7 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Aura Biosciences is a favorable investment for most analysts.

What is Aura Biosciences's price target?

Aura Biosciences's price target, set by 7 Wall Street analysts, averages $22.75 over the next 12 months. The price target range spans from $19 at the low end to $25 at the high end, suggesting a potential 324.44% change from the previous closing price of $5.36.

How does Aura Biosciences stock forecast compare to its benchmarks?

Aura Biosciences's stock forecast shows a 324.44% upside, outperforming the average forecast for the healthcare stocks sector (35.25%) and outperforming the biotech stocks industry (86.56%).

What is the breakdown of analyst ratings for Aura Biosciences over the past three months?

  • April 2025: 42.86% Strong Buy, 57.14% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 42.86% Strong Buy, 57.14% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 42.86% Strong Buy, 57.14% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Aura Biosciences’s EPS forecast?

Aura Biosciences's average annual EPS forecast for its fiscal year ending in December 2025 is $-2.04, marking a 16.57% increase from the reported $-1.75 in 2024. Estimates for the following years are $-2.13 in 2026, $-2.57 in 2027, and $-1.66 in 2028.

What is Aura Biosciences’s revenue forecast?

Aura Biosciences's average annual revenue forecast for its fiscal year ending in December 2025 is $18.7M, reflecting a 0% decrease from the reported $0 in 2024. The forecast for 2026 is $19.2M, followed by $17.5M for 2027, and $109.2M for 2028.

What is Aura Biosciences’s net income forecast?

Aura Biosciences's net income forecast for the fiscal year ending in December 2025 stands at $-85.923M, representing a -1.15% decrease from the reported $-86.919M in 2024. Projections indicate $-84.391M in 2026, $-102M in 2027, and $-65.571M in 2028.